CA
NZ
UK
AU
IND
US
● XORTX is a clinical-stage pharmaceutical company in the speculative, development-stage corner of the market.
● The advance lifted CUPR high onto the day's list of gainers.
● Inspire makes an implantable neurostimulation system for obstructive sleep apnea.
Moderna, Inc. (NASDAQ: MRNA) is seeing sharp profit-taking after a steep, months-long advance. As of this chart snapshot (about 55 minutes before the close), shares are trading at $212.45, down $12.55 (-5.58%), on partial-sessionVolumeof 10.18M shares. The stock opened at $224.50 near Friday's close …
● Market data consensus target is $241.69 from 16 analysts.
● Market data consensus target is $579.81, implying about 13.7% upside.
● The second data set consensus target is $106.82, implying about 20 per cent upside.
● The second data set consensus target is $96 from 17 analysts.
● Market data consensus target is $337.73.
● Market data consensus target is $983.29, implying about 4.87% upside.
Please wait processing your request...